47
Growth Score
pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1375341
EndoProtech is a biotechnology company that develops novel liposome-based therapies for myocardial infarction and alcohol liver disease.
- Gustavo Perez-Abadia: Co-Founder, VP & Treasurer
- Claudio Maldonado: Co-Founder, CEO & President
About the Company
EndoProtech is a biotechnology company that develops novel liposome-based therapies for myocardial infarction and alcohol liver disease. The company advancing solutions to transform human health and enhance the quality of life is EndoProtech’s driving force. It has developed, tested, and demonstrated efficacy with liposomal-based pharmaceuticals in
the areas of heart infarction, alcoholic liver disease, and organ transplantation.
EndoProtech was founded in 2005 and is based in Louisville, KY.
